[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Incidence and Mortal-ity in China, 2016. Journal of the National Cancer Center, 2, 1-9. https://doi.org/10.1016/j.jncc.2022.02.002
|
[3]
|
Ferlay, J., Partensky, C. and Bray, F. (2016) More Deaths from Pancreatic Cancer than Breast Cancer in the EU by 2017. Acta Oncologica, 55, 1158-1160. https://doi.org/10.1080/0284186X.2016.1197419
|
[4]
|
Li, N., Wu, P., Shen, Y., et al. (2021) Predictions of Mor-tality Related to Four Major Cancers in China, 2020 to 2030. Cancer Communications, 41, 404-413. https://doi.org/10.1002/cac2.12143
|
[5]
|
Carioli, G., Malvezzi, M., Bertuccio, P., et al. (2021) European Cancer Mortality Predictions for the Year 2021 with Focus on Pancreatic and Female Lung Cancer. Annals of Oncology, 32, 478-487.
https://doi.org/10.1016/j.annonc.2021.01.006
|
[6]
|
中华医学会肿瘤学分会早诊早治学组. 中华医学会肿瘤学分会胰腺癌早诊早治专家共识[J]. 临床肝胆病杂志, 2020, 36(12): 2675-2680.
|
[7]
|
Zhao, Z. and Liu, W. (2020) Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technology in Cancer Research & Treatment, 19. https://doi.org/10.1177/1533033820962117
|
[8]
|
郭臣, 刘文, 张园园. 多排螺旋CT与MR对胰腺癌的诊断意义探析[J]. 影像研究与医学应用, 2021, 5(24): 194-196.
|
[9]
|
谢晓燕. 超声内镜和超声造影在胰腺局灶性病变诊断中的应用[J]. 中华医学超声杂志(电子版), 2011, 8(7): 1402-1407.
|
[10]
|
Gleeson, F.C., Kipp, B.R., Caudill, J.L., et al. (2010) False Positive Endoscopic Ultrasound Fine Needle Aspiration Cytology: Incidence and Risk Factors. Gut, 59, 586-593. https://doi.org/10.1136/gut.2009.187765
|
[11]
|
Krishnan, K., Bhutani, M.S., Aslanian, H.R., et al. (2021) Enhanced EUS Imaging (with Videos). Gastrointestinal Endoscopy, 93, 323-333. https://doi.org/10.1016/j.gie.2020.06.075
|
[12]
|
Sugimoto, M., Takagi, T., Suzuki, R., et al. (2017) Con-trast-Enhanced Harmonic Endoscopic Ultrasonography in Gallbladder Cancer and Pancreatic Cancer. Fukushima Journal of Medical Science, 63, 39-45.
https://doi.org/10.5387/fms.2017-04
|
[13]
|
Tamagno, G., Scherer, V., Caimo, A., et al. (2018) Endoscopic Ultra-sound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study. Digestion, 98, 112-118. https://doi.org/10.1159/000487939
|
[14]
|
Kitano, M., Yoshida, T., Itonaga, M., et al. (2019) Impact of Endoscopic Ultrasonography on Diagnosis of Pancreatic Cancer. Jour-nal of Gastroenterology, 54, 19-32. https://doi.org/10.1007/s00535-018-1519-2
|
[15]
|
Ge, L., Pan, B., Song, F., et al. (2017) Comparing the Diagnostic Accuracy of Five Common Tumour Biomarkers and CA19-9 for Pancreatic Cancer: A Protocol for a Network Meta-Analysis of Diagnostic Test Accuracy. BMJ Open, 7, e018175. https://doi.org/10.1136/bmjopen-2017-018175
|
[16]
|
Gemmel, C., Eickhoff, A., Helmstädter, L., et al. (2009) Pan-creatic Cancer Screening: State of the Art. Expert Review of Gastroenterology & Hepatology, 3, 89-96. https://doi.org/10.1586/17474124.3.1.89
|
[17]
|
Kamisawa, T., Wood, L.D., Itoi, T., et al. (2016) Pancreatic Cancer. The Lancet, 388, 73-85.
https://doi.org/10.1016/S0140-6736(16)00141-0
|
[18]
|
Lee, B. and Gibbs, P. (2019) Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer. Journal of Personalized Medicine, 9, Article No. 20. https://doi.org/10.3390/jpm9020020
|
[19]
|
Daamen, L.A., Groot, V.P., Heerkens, H.D., et al. (2018) Systematic Re-view on the Role of Serum Tumor Markers in the Detection of Recurrent Pancreatic Cancer. HPB, 20, 297-304. https://doi.org/10.1016/j.hpb.2017.11.009
|
[20]
|
He, J. (2014) Management of Borderline and Locally Advanced Pancreatic Cancer: Where Do We Stand? World Journal of Gastroenterology, 20, 2255-2266. https://doi.org/10.3748/wjg.v20.i9.2255
|
[21]
|
Dai, H.M., Hong, X.F., Pang, H.Y., Wu, W.M. and Zhao, Y.P. (2019) The Effect of Para-Aortic Lymph Node Metastasis on the Resectability of Pancreatic Cancer. Chinese Journal of Surgery, 57, 68-71.
|
[22]
|
Shin, S.H., Kim, S.C., Song, K.B., et al. (2015) A Comparative Study of Laparoscopic vs. Open Distal Pancreatectomy for Left-Sided Ductal Adenocarcinoma: A Propensity Score-Matched Analysis. Journal of the American College of Surgeons, 220, 177-185. https://doi.org/10.1016/j.jamcollsurg.2014.10.014
|
[23]
|
Strobel, O., Neoptolemos, J., Jager, D. and Buchler, M.W. (2019) Optimizing the Outcomes of Pancreatic Cancer Surgery. Na-ture Reviews Clinical Oncology, 16, 11-26. https://doi.org/10.1038/s41571-018-0112-1
|
[24]
|
Seufferlein, T., Ham-mel, P., Delpero, J.R., et al. (2019) Optimizing the Management of Locally Advanced Pancreatic Cancer with a Focus on Induction Chemotherapy: Expert Opinion Based on a Review of Current Evidence. Cancer Treatment Reviews, 77, 1-10. https://doi.org/10.1016/j.ctrv.2019.05.007
|
[25]
|
Springfeld, C., et al. (2019) Chemotherapy for Pancreatic Cancer. La Presse Médicale, 48, e159-e174.
https://doi.org/10.1016/j.lpm.2019.02.025
|
[26]
|
Raza, M.H., Raza, M.H., Arshad, A., et al. (2019) Microbiota in Cancer Development and Treatment. Journal of Cancer Research and Clinical Oncology, 145, 49-63. https://doi.org/10.1007/s00432-018-2816-0
|
[27]
|
Riquelme, E., Maitra, A. and McAllister, F. (2018) Immunother-apy for Pancreatic Cancer: More than Just a Gut Feeling. Cancer Discovery, 18, 386-388. https://doi.org/10.1158/2159-8290.CD-18-0123
|